1. Home
  2. FLGT vs SLSR Comparison

FLGT vs SLSR Comparison

Compare FLGT & SLSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FLGT
  • SLSR
  • Stock Information
  • Founded
  • FLGT 2011
  • SLSR 2018
  • Country
  • FLGT United States
  • SLSR Canada
  • Employees
  • FLGT N/A
  • SLSR N/A
  • Industry
  • FLGT Medical Specialities
  • SLSR
  • Sector
  • FLGT Health Care
  • SLSR
  • Exchange
  • FLGT Nasdaq
  • SLSR NYSE
  • Market Cap
  • FLGT 508.7M
  • SLSR 539.0M
  • IPO Year
  • FLGT 2016
  • SLSR N/A
  • Fundamental
  • Price
  • FLGT $17.62
  • SLSR $3.40
  • Analyst Decision
  • FLGT Hold
  • SLSR Buy
  • Analyst Count
  • FLGT 1
  • SLSR 2
  • Target Price
  • FLGT $16.00
  • SLSR $10.00
  • AVG Volume (30 Days)
  • FLGT 727.9K
  • SLSR 50.8K
  • Earning Date
  • FLGT 05-02-2025
  • SLSR 05-08-2025
  • Dividend Yield
  • FLGT N/A
  • SLSR N/A
  • EPS Growth
  • FLGT N/A
  • SLSR N/A
  • EPS
  • FLGT N/A
  • SLSR N/A
  • Revenue
  • FLGT $283,470,000.00
  • SLSR N/A
  • Revenue This Year
  • FLGT $11.70
  • SLSR N/A
  • Revenue Next Year
  • FLGT $9.90
  • SLSR N/A
  • P/E Ratio
  • FLGT N/A
  • SLSR N/A
  • Revenue Growth
  • FLGT N/A
  • SLSR N/A
  • 52 Week Low
  • FLGT $14.57
  • SLSR $2.88
  • 52 Week High
  • FLGT $25.11
  • SLSR $3.76
  • Technical
  • Relative Strength Index (RSI)
  • FLGT 57.62
  • SLSR 47.22
  • Support Level
  • FLGT $16.51
  • SLSR $3.43
  • Resistance Level
  • FLGT $17.20
  • SLSR $3.62
  • Average True Range (ATR)
  • FLGT 0.56
  • SLSR 0.19
  • MACD
  • FLGT 0.04
  • SLSR -0.02
  • Stochastic Oscillator
  • FLGT 98.23
  • SLSR 47.06

About FLGT Fulgent Genetics Inc.

Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.

About SLSR SOLARIS RESOURCES INC

Solaris Resources Inc is advancing a portfolio of copper and gold assets in the Americas, which includes a high-grade resource with expansion and additional discovery potential at the Warintza copper and gold project in Ecuador; discovery potential on the grass-roots Tamarugo project in Chile and Capricho and Paco Orco projects in Peru, and the La Verde joint venture project.

Share on Social Networks: